Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)

Clinical trial NCT04939441 · UNKNOWN

Trial details

NCT number: NCT04939441
Sponsor: Jidong Jia
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2021-04-20
Primary completion: 2024-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.